1. Home
  2. HRMY vs SNDA Comparison

HRMY vs SNDA Comparison

Compare HRMY & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$36.75

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

N/A

Current Price

$34.13

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRMY
SNDA
Founded
2017
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
HRMY
SNDA
Price
$36.75
$34.13
Analyst Decision
Buy
Buy
Analyst Count
12
6
Target Price
$48.08
★ $49.50
AVG Volume (30 Days)
★ 993.4K
422.6K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 7.97
N/A
EPS
★ 1.84
N/A
Revenue
★ $868,453,000.00
$381,141,000.00
Revenue This Year
$18.17
$120.42
Revenue Next Year
$13.71
$17.55
P/E Ratio
$20.01
★ N/A
Revenue Growth
21.51
★ 25.24
52 Week Low
$25.90
$29.50
52 Week High
$43.49
$44.39

Technical Indicators

Market Signals
Indicator
HRMY
SNDA
Relative Strength Index (RSI) 50.13 39.72
Support Level $36.74 $32.95
Resistance Level $39.40 $37.18
Average True Range (ATR) 1.50 1.08
MACD 0.17 0.10
Stochastic Oscillator 80.36 37.70

Price Performance

Historical Comparison
HRMY
SNDA

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

Share on Social Networks: